Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyn H Jones

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
RSC Chemical Biology|September 21, 2022
Cereblon covalent modulation through structure-based design of histidine targeting chemical probesJustin T Cruite, Geoffrey P Dann, Jianwei Che, et al.
Journal of Medicinal Chemistry|April 10, 2023
Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic FusionsYang Gao, Baishan Jiang, Hellen Kim, et al.
Cell|May 1, 2021
LanCLs add glutathione to dehydroamino acids generated at phosphorylated sites in the proteomeKuan-Yu Lai, Sébastien R G Galan, Yibo Zeng, et al.
Journal of Medicinal Chemistry|March 4, 2017
Design of Potent mRNA Decapping Scavenger Enzyme (DcpS) Inhibitors with Improved Physicochemical Properties To Investigate the Mechanism of Therapeutic Benefit in Spinal Muscular Atrophy (SMA)Ariamala Gopalsamy, Arjun Narayanan, Shenping Liu, et al.
Plos One|October 8, 2013
Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in miceDavid C Pryde, Lyn H Jones, David P Gervais, et al.
Nature Reviews. Drug Discovery|April 20, 2026
Safety considerations for cereblon-recruiting targeted protein degradersHelen Garside, Amy Aslamkhan, Danette L Daniels, et al.
ACS Chemical Biology|October 17, 2024
Novel Corrector for Variants of SLC6A8: A Therapeutic Opportunity for Creatine Transporter DeficiencyLara N Gechijian, Giovanni Muncipinto, T Justin Rettenmaier, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPDLyn H Jones, Helen Baldock, Mark E Bunnage, et al.
Cell Reports|June 9, 2021
Human amyotrophic lateral sclerosis excitability phenotype screen: Target discovery and validationXuan Huang, Kasper C D Roet, Liying Zhang, et al.
Plos One|September 26, 2017
In vitro and in vivo effects of 2,4 diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS: Context-specific modulation of SMN transcript levelsJonathan J Cherry, Christine J DiDonato, Elliot J Androphy, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
RSC Chemical Biology|September 21, 2022
Cereblon covalent modulation through structure-based design of histidine targeting chemical probesJustin T Cruite, Geoffrey P Dann, Jianwei Che, et al.
Journal of Medicinal Chemistry|April 10, 2023
Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic FusionsYang Gao, Baishan Jiang, Hellen Kim, et al.
Cell|May 1, 2021
LanCLs add glutathione to dehydroamino acids generated at phosphorylated sites in the proteomeKuan-Yu Lai, Sébastien R G Galan, Yibo Zeng, et al.
Journal of Medicinal Chemistry|March 4, 2017
Design of Potent mRNA Decapping Scavenger Enzyme (DcpS) Inhibitors with Improved Physicochemical Properties To Investigate the Mechanism of Therapeutic Benefit in Spinal Muscular Atrophy (SMA)Ariamala Gopalsamy, Arjun Narayanan, Shenping Liu, et al.
Plos One|October 8, 2013
Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in miceDavid C Pryde, Lyn H Jones, David P Gervais, et al.
Nature Reviews. Drug Discovery|April 20, 2026
Safety considerations for cereblon-recruiting targeted protein degradersHelen Garside, Amy Aslamkhan, Danette L Daniels, et al.
ACS Chemical Biology|October 17, 2024
Novel Corrector for Variants of SLC6A8: A Therapeutic Opportunity for Creatine Transporter DeficiencyLara N Gechijian, Giovanni Muncipinto, T Justin Rettenmaier, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPDLyn H Jones, Helen Baldock, Mark E Bunnage, et al.
Cell Reports|June 9, 2021
Human amyotrophic lateral sclerosis excitability phenotype screen: Target discovery and validationXuan Huang, Kasper C D Roet, Liying Zhang, et al.
Plos One|September 26, 2017
In vitro and in vivo effects of 2,4 diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS: Context-specific modulation of SMN transcript levelsJonathan J Cherry, Christine J DiDonato, Elliot J Androphy, et al.
Pageof 12